Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 20Sarcoma 4Lymphoid 4Other solid neoplasm 1Other hematologic neoplasm 1Dermatologic 1Breast 1

Conditions

Mesothelioma, Malignant 2Solitary Fibrous Tumor, Pleural 1Solid Tumors 1Sarcoma 1Retinoblastoma 1Neuroblastoma 1Mesothelioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Thiotepa 5Filgrastim 5Peripheral Blood Stem Cell Transplantation 4Etoposide 4Busulfan 4Melphalan 3Granulocyte Colony-Stimulating Factor 3Carboplatin 3Radiotherapy 2Mesna 2Ifosfamide 2Cisplatin 2sargramostim 1etoposide phosphate 1becatecarin 1Vincristine 1Ursodeoxycholic Acid 1Temozolomide 1Tamoxifen 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Methotrexate 1Leukapheresis 1Leucovorin 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Methotrexate × Other solid neoplasm × Clear all
NCT00003273 2015-12-03

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NYU Langone Health

Phase 2 Withdrawn
CNSOther solid neoplasmSarcoma

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡